Signaling and metabolism in cancer: Endocrine pancreas deficiency and hybrid anabolism - Catabolism, drugs that undo the process

Cancer Therapy

Volumn 10, Issue , 2014, Pages 1-12

  Israël, Maurice ^a  

^a CNRS   (France)

Author keywords

Anti cancer drugs; Cancer metabolism; GABA; Glucagon; Growth hormone; IGF; Insulin; Signaling

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN TYROSINE PHOSPHATASE 1B;

ARTICLE; BIOSYNTHESIS; CATABOLISM; DRUG MIXTURE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METABOLIC REGULATION; METABOLIC REWIRING; METABOLISM; MOLECULARLY TARGETED THERAPY; NONHUMAN; PANCREAS ISLET; SIGNAL TRANSDUCTION;

EID: 84896857166     PISSN: 15439135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Abolhassani M, Guais A, Sanders E, Campion F, Fichtner I, Bonte J, Baronzio G, Fiorentini G, Israël M, Schwartz L. (2012) Screening of wellestablished drugs targeting cancer metabolism: reproducibility of the efficacy of highly effective drug combination in mice. Invest New Drugs 30 (4), 1331-42.
2. Baker MA, Hetherington L, Aitken RJ. (2006) Identification of Src as a key PKA stimulated tyrosine kinase involved in the capacitationassociated hyperactivation of murine spermatozoa. J Cell Sci 119, 3182-92.
3. Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, Brusselmans K, Verhoeven G, Swinnen JV. (2007) Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res 67(17), 8180-7, J Biol Chem 286 (25):(22323-30)
4. Berkson BM, Rubin DM, Berkson AJ. (2006) The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol. Integr Cancer Ther 5 (1), 83-9.
5. Benavides J, Gimenez C, Valdivieso F, Mayor F. (1976) Effect of phenylalanine metabolites on the activities of enzymes of ketone-body utilization in brain of suckling rats. Biochem J. 160(2), 217-22.
6. Bettaieb A, Bakke J, Nagata N, Matsumo K, Xi Y, Liu S, AbouBechara D, Melhem R, Stanhope K, Cummings B, Graham J, Bremer A, Zhang S, Lyssiotis CA, Zhang ZY, Cantley LC, Havel PJ, Haj FG. (2013) Protein tyrosine phosphatase 1B regulates pyruvate kinase M2 tyrosine phosphorylation. J Biol Chem 288 (24), 17360-71.
7. Beuster G, Zarse K, Kaleta C, Thierbach R, Kiehntopf M, Steinberg P, Schuster S, Ristow M. (2011) Inhibition of alanine aminotransferase in silico and in vivo promotes mitochondrial metabolism to impair malignant growth. J Biol Chem 286 (25), 22323-30.
8. Bonnet S, Archer SL, Allalunis-Turner J, Armony A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, Thebaud B, Michelakis ED. (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11 (1), 37-51.
9. Brady MJ, Saltiel AR. (2001) The role of protein phosphatase-1 in insulin action. Recent Prog Horm Res 56, 157-73.
10. Bucay AH. (2007) The biological significance of cancer; mitochondria as a cause of cancer and the inhibition of glycolysis with citrate as a cancer treatment. Medical Hypotheses 69, 826-828.
11. Burgos SA, Kim JJ, Dai M, Cant JP. (2013) Energy depletion of bovine mammary epithelial cells activates AMPK and suppresses protein synthesis trough inhibition of mTORC1 signaling. Horm Metab 45 (3), 183-9.
12. Burmeister BT, Taglieri DM, Wang L, Carnegie GK. (2012) Scr Homology 2 Domain-containing Phosphatase 2 (Shp2) is a component of the Akinase-anchoring Protein (AKAP)-Lbc complex and is inhibited by Protein Kinase A (PKA) under pathological hypertrophic conditions in the heart. J Biol Chem 287, 40535-46.
13. Cai S-L, Tee AR, Short JD, Bergeron JM, Kim J, Shen J, Guo R, Johanson Cl, Kiguchi K, Walker CL. (2006) Activity of TSC2 is inhibited by AKTmediated phosphorylation and membrane partitioning. JCB 173 (2), 279-288.
14. Chang CI, Liao JC, Kuo L. (2001) Macrophage arginase promotes cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61 (3), 1100-6.
15. Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC. (2008) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452 (7184), 181-186.
16. Chung TW, Hitosugi T, Fan J, Wang X, Gu TL, Roesel JL, Boggon T, Chen ZG, Khuri FR, Kang S, Chen J. (2011) Abstract 1257: Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Proceedings AACR 102 Annual meeting Orlando. Cancer Research volume 71 issues 8 supplement 1.
17. Dadke S, Kusari A, Kusari J. (2001) Phosphorylation and activation of protein tyrosine phosphatase (PTP) 1B by insulin receptor. Mol Cell Biochem 221 (1-2), 147-54.
18. Damuni Z, Xiong H, Li M. (1994) Autophosphorylation-activated protein kinase inactivates the protein tyrosine phosphatase activity of protein phosphatase 2A. FEBS letters 352, 311-314.
19. Dieni C. (2012) Make up your mind! When phosphorylation turns enzymes "ON" or "OFF" in: http://www.benchfly.com/blog/make-up-yourmind-when-phosphorylation-turns-enzymes
20. Fan G, Balou LM, Lin RZ. (2003) Phospholipase Cindependent activation of glycogensynthase kinase-3beta and C-terminal Src kinase by G alpha q. J Biol Chem 268 (52), 52432-6.
21. Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, Mills GB. (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA. 97(22), 11960-5.
22. Fragasso G, Spoladore R, Cuko A, Palloshi A. (2007) Modulation of fatty acids oxidation in heart failure by selective pharmacological inhibition of 3-ketoacyl coenzyme-A thiolase. Curr Clin Pharmacol (3), 190-6
23. Gernez A. Néo-postulats biologiques et pathologiques. Editions "La vie Claire". (1975).
24. Guichard C, Pedruzzi E, Fay M, Marie JC, Braut-Boucher F, Daniel F, Grodet A, Gougerot-Pocidalo MA, Chastre E, Kotelevets L, Lizard G, Vandewalle A, Driss F, Ogier-Denis E. (2006) Dihydroxyphenylethanol induces apoptosis by activating serine/threonine phosphatase PP2A and promotes the endoplasmic reticulum stress response in human carcinoma. Carcinogenesis 27 (9), 1812-27.
25. Ha J, Daniel S, Broyless SS, Kim KH. (1994) Critical phosphorylation sites for sites for acetyl-CoA carboxylase activity. J Biol Chem 269 (35), 22162-8.
26. Hao G, Xie L, Gross SS. (2004) Argininosuccinate synthase is reversibly inactivated by Snitrosylation in vitro and in vivo. J Biol Chem 279 (35), 36192-200.
27. Hitosugi T, Fan J, Chung TW, Lythgoe K, Wang X, Xie J, Ge Q, Gu TL, Polakiewicz RD, Roesel JL, Chen GZ, Boggon TJ, Lonial S, Fu H, Khuri FR, Kang S, Chen J. (2011) Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell 44 (6), 846-8.
28. Icard P, Lincet H (2012) Global view of the biochemical pathways involved in the regulation of metabolism of cancer cells. Biochimica et Biophysica Acta 1826, 423-433.
29. Israël M, Schwartz L (2005) In: Cancer a dysmethylation syndrome John Libbey eurotext
30. Israël M, Schwartz L. (2011a) The metabolic advantage of tumor cells. Molecular cancer 10 (70), 1-12.
31. Israël M, Schwartz L. (2011b) On the metabolic origin of cancer: Substances that target tumor metabolism. Biomedical Research (Aligarh) 22 (2), 130-164.
32. Israël M. (2012a) In Cancer metabolism Special issue of Biomedical Research (Aligarh) in memory of Erich Eigenbrodt. Volume 23. Editor MA Qayyum.
33. Israël M. (2012b) A possible primary cause of cancer: deficient cellular interactions in endocrine pancreas. Molecular Cancer 11, 63-68.
34. Israël M. (2012c) A primary cause of cancer: GABA deficiency in endocrine pancreas. Cancer Therapy 8, 171-183.
35. Kang S, Chen J. (2011) Abstract 1257: Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Proceedings AACR 102 Annual meeting Orlando. Cancer Research volume 71 issue 8 supplement 1
36. King AR, Dotsey EY, Lodola A, Jung KM, Ghomian A, Qui Y, Fu J, Mor M, Piomelli D. (2009) Discovery of potent and reversible monoacylglycerol lipase inhibitors. Chem Biol 16 (10), 1045-52.
37. King MW The Pyruvate Dehydrogenase complex (2013) In: http://themedicalbiochemistrypage.org/tcacycle. php
38. Kozu T, Linuma G, Ohashi Y, Saito Y, Akasu T, Saito D, Alexander DB, Ligo M, Kakizoe T, Tsuda H. (2009) Effect of orally administered bovine lactoferrin on growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev Res (Phila) 2 (11), 975-83.
39. Li W, Zhao Y. (2013) Whitaferin A suppresses tumor promoter 12-O-tetradecanoylphorbol 13-acetateinduced decreases in isocitrate dehydrogenase 1 activity and mitochondrial function in skin epidermal JB6 cells. Cancer Sci 104 (2), 143-8.
40. Mazurek S, Eigenbrodt E. (2003) The tumor metabolome. Anticancer Res 23 (2A), 1149-1154.
41. Newgard CB, Hwang PK, Fletterick RJ. (1989) The family of Glycogen phosphorylases: structure and function. Critical Reviews in Biochemistry and Molecular Biology 24 (1), 69-99.
42. Obara Y, Labudda K, Dillon TJ, Stork PJ. (2004) PKA phosphorylation of Src mediatesRap1 activation inNGF and cAMP signaling in PC12 cells. J Cell Sci 117, 6085-94.
43. Olianas MC, Dedoni S, Onali P. (2011) d-Opioid receptors stimulate GLUT1-mediated glucose uptake through Src-and IGF-1 receptor dependent activation of PI3-kinase signaling in CHO cells. British Journal of Pharmacology 163, 624-637.
44. Phelps DC, Hatefi Y. (1981) Inhibition of D (--)-betahydroxybutyrate dehydrogenase by butanedione, phenylglyoxal, and diethyl pyrocarbonate. Biochemistry. 20 (3), 459-63.
45. Philpott CC, Klausner RD, Rouault TA. (1994) The bifunctional iron-responsive element binding protein/cytosolic aconitase: the role of active-site residues in ligand binding and regulation. Proc Natl Acad Sci USA 91 (15), 7321-25.
46. Podesta FE, Plaxton WC. (1993) Activation of pyruvate kinase by polyethylene glycol. Plant Physiol 103, 285-88.
47. Preuss J, Richardson AD, Pinkerton A, Hedrick M, Sergienko E, Rahlfs S, Becker K, Bode L. (2013) Identification and characterization of novel human glucose-6-phosphatase inhibitors. J Biomol Screen 18 (3), 286-97.
48. Ravichandra LV, Chen H, Li Y, Quon MJ. (2001) Phosphorylation of PTP1B at Ser (50) by Akt impairs its ability to dephosphorylate the insulin receptor. Mol Endocrinol (10), 1768-80.
49. Roskoski R Jr. (2005) Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331(1), 1-14.
50. Rous P. (1910) A transmissible avian neoplasm (sarcoma of the common fowl). J Exp Med 12, 696-705.
51. Rous P. (1911) A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13, 397-411
52. Rylatt DB, Aitken A, Bilham T, Condon GD, Embi N, Cohen P. (1980) Glycogen synthase from rabbit skeletal muscle at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phophorylase kinase. Eur J Biochem 107 (2), 529-37. See: http://en.wikipedia.org/wiki/Glycogen_synthase
53. Schalinske KL, Chen OS, Eisenstein RS. (1998) Iron differentially stimulates translation of mitochondrial aconitase and ferritin mRNAs in mammalian cells. Implications for iron regulatory proteins as regulators of mitochondrial citrate utilization. J Biol Chem 273 (6), 3740-6.
54. Schmitt JN, Stork PJ. (2002) PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1. Mol Cell 1, 85-94.
55. Schulz H. (1983) Metabolism of 4-pentenoic acid and inhibition of thiolase by metabolites of 4-pentenoci acid. Biochemistry 22(8), 1827-32.
56. Schwartz AG, Pashko LL. (2004) Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase and longevity. Ageing Res Rev 3 (2), 171-87.
57. Schwartz L, Abolhassani M, Guais A, Sanders E, Steyaert JM, Campion F, Israël M. (2010) A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results. Oncol Rep 23 (5), 1407-16.
58. Selamnia M, Robert V, Mayeur C, Duée PH, Blachier F. (1998) Effects of L-valine on growth and polyamine metabolism in human colon carcinoma cells. Biochim Biophys Acta 1379 (1), 151-60.
59. Stehelin D, Varmus HE, Bishop JM, Vogt PK. (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260, 170-173.
60. Sugita H, Kaneki M, Tokunaga E, Sugita M, Koike C, Yasuhara S, Tompkins RG, Martyn JA. (2002) Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab. 282 (2), E386-94.
61. Vogel Z, Barg J, Levy R, Saye D Heldman E, Mechoulam R. (1993) Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 61(1), 352-5
62. Warburg O. (1956) On the origin of cancer cells. Science 123 (3191), 309-314.
63. Warburg. O. (1956) On respiratory impairment in cancer cells. Science 124 (3215), 269-270.
64. Watt MJ, Holmes AG, Pinnamaneni SK, Gamham AP, Steinberg GR, Kemp BE, Febbraio MA. (2006) Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab 290 (3), E500-8.
65. Wheatley DN, Campbell E. (2003) Arginine deprivation, growth inhibition and tumor cell death: Deficient utilization of citrulline by malignant cell. Br J Cancer 89 (3), 573-6.
66. Yamada E, Pessin JE, Kurland IJ, Schwartz GL, Bastie CC. (2010) Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1. Cell Metab 11(2), 113-24.